Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Immunotherapy”

469 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 469 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06814067
What this trial is testing

Phase II Multi-centered Study of Perioperative Ivonescimab Versus Pembrolizumab Combined with Standard of Care (SOC) in Patients with Resectable, Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell CarcinomaHead and Neck Squamous Cell Carcinoma HNSCC
Fudan University 80
Testing effectiveness (Phase 2)WithdrawnNCT03872505
What this trial is testing

Pre-operAtive Non-Anthracycline Chemotherapy, Durvalumab +/- RAdiation Therapy in Triple Negative Breast Cancer

Who this might be right for
Breast CancerTriple Negative Breast Cancer
Cedars-Sinai Medical Center
Testing effectiveness (Phase 2)Study completedNCT05577702
What this trial is testing

Efficacy, Safety, and Pharmacodynamics of Tislelizumab Monotherapy and Multiple Tislelizumab-based Immunotherapy Combinations in Participants With Resectable Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
BeiGene 121
Early research (Phase 1)Looking for participantsNCT06902376
What this trial is testing

XL092 and Cemiplimab in BRAF WT Thyroid Cancer

Who this might be right for
Anaplastic Thyroid CancerThyroid CancerBRAF Mutation-Related Tumors
UNC Lineberger Comprehensive Cancer Center 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07161115
What this trial is testing

Involve-site Radiotherapy Combined With Chemotherapy and Immunotherapy as Neoadjuvant Treatment for Locally Advanced Rectal Cancer

Who this might be right for
Rectal Adenocarcinoma
Longhao Li 60
Not applicableNot Yet RecruitingNCT06418139
What this trial is testing

Association of Pembrolizumab Infusion Time and Efficacy in Patients With Non-metastatic Triple-negative Breast Cancer (TNBC) Treated With Neoadjuvant Chemotherapy and Immunotherapy

Who this might be right for
Non-Metastatic Breast Carcinoma
Assistance Publique - Hôpitaux de Paris 450
Testing effectiveness (Phase 2)Looking for participantsNCT07165847
What this trial is testing

Neoadjuvant Radiotherapy Plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and GE-junction Cancer : A Randomized, Two-arm, Prospective Trial (TRIUNITE-05)

Who this might be right for
ImmunotherapyGastric Cancer (GC)Radiotherapy+2 more
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 40
Testing effectiveness (Phase 2)Looking for participantsNCT06114225
What this trial is testing

Pulmonary Resectable Osteosarcoma Treated by Metastasectomy and Pre-operative Immunotherapy and Stereotactic Body Radiotherapy (PROMIS): a Prospective Clinical Trial

Who this might be right for
Osteosarcoma
Ruijin Hospital 43
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06396585
What this trial is testing

The Efficacy and Safety of Tislelizumab Combined With Anlotinib and S1 Plus Oxaliplatin as Neoadjuvant Therapy for the Locally Advanced Adenocarcinoma of Esophagogastric Junction

Who this might be right for
Immunotherapy Gastroesophageal Junction
Fujian Cancer Hospital 28
Not applicableStudy completedNCT06453395
What this trial is testing

PPIO-009 Tumor Regression Grade and Tumor Location in Esophageal Cancer

Who this might be right for
Tumor Regression Grade
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 248
Not applicableLooking for participantsNCT06349512
What this trial is testing

68Ga-FAPI-46 PET/CT for Predicting Histological Response in Triple-negative Breast Cancer (FAP-IT)

Who this might be right for
Triple Negative Breast Cancer
Institut Curie 60
Testing effectiveness (Phase 2)UnknownNCT05861557
What this trial is testing

Neoadjuvant Radiotherapy Combined With Toripalimab for Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Tianjin Medical University General Hospital 23
Testing effectiveness (Phase 2)Looking for participantsNCT07104149
What this trial is testing

Neoadjuvant Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer

Who this might be right for
Female, Age ≥ 18 Years OldNo Previous Systemic Treatment for the Current Disease, Including Surgery, Antitumor Radiochemotherapy/ImmunotherapyECOG Score of 0-1+6 more
The First Affiliated Hospital of Zhengzhou University 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT06059547
What this trial is testing

Neoadjuvant Immunotherapy Combined With the Anti-GDF-15 Antibody Visugromab to Treat Muscle Invasive Bladder Cancer

Who this might be right for
Bladder CancerAdult Solid Tumor
CatalYm GmbH 31
Early research (Phase 1)Looking for participantsNCT06225921
What this trial is testing

Neoadjuvant Adebrelimab With Dalpiciclib for Resectable Esophageal Squamous Cell Carcinomas

Who this might be right for
Esophageal Squamous Cell Carcinoma
West China Hospital 6
Testing effectiveness (Phase 2)Looking for participantsNCT05440864
What this trial is testing

Durvalumab and Tremelimumab in Resectable HCC

Who this might be right for
Hepatocellular Carcinoma
University Health Network, Toronto 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT03515798
What this trial is testing

Study of Immunotherapy in Combination With Chemotherapy in HER2-negative Inflammatory Breast Cancer

Who this might be right for
Inflammatory Breast Cancer
Institut Paoli-Calmettes 52
Large-scale testing (Phase 3)Looking for participantsNCT06794775
What this trial is testing

SWE-NEO: Swedish NeoAdjuvant Trial Comparing Monotherapy to Combined Immunotherapy in Resectable Stage III Melanoma

Who this might be right for
Malignant Melanoma Stage III
Hildur Helgadottir 128
Very early researchActive Not RecruitingNCT03387553
What this trial is testing

HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer

Who this might be right for
Breast CancerBreast Cancer FemaleBreast Cancer, Male+5 more
H. Lee Moffitt Cancer Center and Research Institute 31
Testing effectiveness (Phase 2)Looking for participantsNCT06272214
What this trial is testing

Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy

Who this might be right for
Adjuvant Radiotherapy
Zhejiang Cancer Hospital 146
Load More Results